Aptose Biosciences Inc. (APTOF)
↓ Download CSV- Sector Manufacturing
- Incorporated A6
- Fiscal year ends Dec 31
In fiscal 2025, Aptose Biosciences Inc. reported revenue of $0. The company ran a net loss. It held $10.01M in total assets against $37.18M in total liabilities.
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — |
| Net Income | -$25.47M | -$25.43M | -$51.21M | -$41.82M | -$65.35M | -$55.24M | -$26.28M | -$28.87M | -$11.64M | — |
| EPS (Diluted) | $-10.41 | $-36.38 | $-227.43 | $-6.80 | $-0.73 | — | — | — | — | — |
| Total Assets | $10.01M | $10.13M | $12.99M | $51.03M | $82.53M | $126.26M | $100.48M | $16.87M | $11.97M | — |
| Total Liabilities | $37.18M | $14.67M | $15.89M | $13.29M | $8.29M | $7.35M | $6.55M | $2.79M | — | — |
| Shareholders' Equity | -$27.17M | -$4.54M | -$2.90M | $37.74M | $74.24M | $118.92M | $93.93M | $14.08M | $10.20M | $7.33M |
| Cash & Equivalents | $935.0K | $6.15M | $9.25M | $36.97M | $39.11M | $117.39M | $79.84M | $15.30M | $10.63M | — |
| Operating Cash Flow | -$21.99M | -$35.98M | -$44.59M | -$32.32M | -$43.30M | -$33.89M | -$21.56M | -$23.21M | -$10.22M | — |
| Capital Expenditures | $0 | $5.0K | $29.0K | $24.0K | $212.0K | $79.0K | $102.0K | $329.0K | $13.0K | — |
| Shares Outstanding | 2.55M | 2.01M | 264.7K | 6.16M | 92.22M | 88.88M | 76.11M | 38.16M | 27.50M | — |